Keros Therapeutics, Inc. (KROS) News
Track canonical SquawkNews coverage tagged to KROS, Keros Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
KROS - Keros Therapeutics Reports Second Quarter 2026 Financial Results
KROS - Keros Therapeutics Reports Second Quarter 2026 Financial Results
EARNINGS | Aug 03, 2026, 08:01 PM UTC
H
Keros Therapeutics Receives $20M Milestone Payment
Keros Therapeutics gets $20M payment from Takeda
EQUITY | Jul 30, 2026, 08:06 PM UTC
H
KROS Receives Milestone Payment
KROS receives development milestone payment
EQUITY | Jul 30, 2026, 08:01 PM UTC
L
KROS Keros Therapeutics - keith regnante resigns as CFO effective August 3, 2026 - SEC filing - Appoints annita tanini interim Principal fin
KROS Keros Therapeutics - keith regnante resigns as CFO effective August 3, 2026 - SEC filing - Appoints annita tanini interim Principal financial officer effective August 4, 2026 - SEC filing
REGULATION | Jul 22, 2026, 08:03 PM UTC